Elysium Health™ Research Demonstrates Improvements in Menopause Symptoms and Estrogen Balance with Basis™ and Reveals New Insights into NAD+ Metabolism
Findings demonstrate significant improvements in major disruptive menopausal symptoms and a beneficial increase in E2/E1 ratio NEW YORK, July 9, 2026 /PRNewswire/ -- Elysium Health, Inc.™, the leading longevity science company, today announced new research published in Frontiers in Aging...
Findings demonstrate significant improvements in major disruptive menopausal symptoms and a beneficial increase in E2/E1 ratio NEW YORK, July 9, 2026 /PRNewswire/ -- Elysium Health, Inc.™, the leading longevity science company, today announced new research published in Frontiers in Aging...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.